Table 2.
Strategy for Senescent Cell Elimination | Drug | Drug Target | References |
---|---|---|---|
SASP Inhibition | Rapamycin | mTor | [186,187] |
Sertraline | mTor | [188] | |
Torin1 | mTor | [189] | |
Pacritinib | JAK2 | [190] | |
Ruxolitinib | JAK1/2 | [191] | |
Senolytics | Dasatinib | Src kinase, BCR/Abl | [192,193] |
Quercetin | Bcl-xL | [192,193] | |
A-1331852 | Bcl-xL | [194] | |
ABT-263, -737 | Bcl-2, Bcl-xL and Bcl-W | [195] | |
XL413 | CDC7 | [188] | |
BETd | BRD4/NHEJ | [182] | |
Ouabain (cardiac glycoside) | Na+/K+-ATPase | [196] | |
Immunotherapy | Poly(I:C) | NK cell activation | [197] |
CAR-T | uPAR | [198] |